Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Career
    • Practice Management
      • Reimbursement & Coding
      • Legal
      • Operations
    • Awards
    • Certification
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Compensation Reports
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • By the Numbers
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • mTBI Resource Center
    • ACEP.org
    • ACEP Knowledge Quiz
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • Issue Archives
  • Archives
    • Brief19
    • Coding Wizard
    • Images in EM
    • Care Team
    • Quality & Safety
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

Diltiazem Achieves More Rapid Rate Control in Atrial Fibrillation than Metoprolol

By Ken Milne, MD | on January 15, 2016 | 2 Comments
CME CME Now Skeptics' Guide to EM
Share:  Print-Friendly Version
Diltiazem Achieves More Rapid Rate Control in Atrial Fibrillation than Metoprolol
You Might Also Like
  • ACEP15 Session: Treatment Update for Atrial Fibrillation
  • Get the Latest Update on Atrial Fibrillation
  • Atrial Fibrillation Assessment Tips, Via a Dance Club Analogy
Explore This Issue
ACEP Now: Vol 35 – No 01 – January 2016

Pages: 1 2 3 | Single Page

Topics: Atrial FibrillationCardiovascularCritical CareDiltiazemEmergency DepartmentEmergency MedicineMetoprolol

Related

  • Phenylephrine and Epinephrine Push-Dose Vasopressors

    February 10, 2026 - 0 Comment
  • Why the Nonrebreather Should be Abandoned

    December 3, 2025 - 0 Comment
  • Non-Invasive Positive Pressure Ventilation in the Emergency Department

    October 1, 2025 - 0 Comment

Current Issue

ACEP Now: February 2026 (Digital)

Read More

About the Author

Ken Milne, MD

Ken Milne, MD, is chief of emergency medicine and chief of staff at South Huron Hospital, Ontario, Canada. He is on the Best Evidence in Emergency Medicine faculty and is creator of the knowledge translation project the Skeptics Guide to Emergency Medicine.

View this author's posts »

2 Responses to “Diltiazem Achieves More Rapid Rate Control in Atrial Fibrillation than Metoprolol”

  1. January 24, 2016

    HC Reply

    Anyone adding IV magnesium to IV Cardizem & obtaining higher success of spontaneous conversion?

  2. December 26, 2016

    FMarkMoore/MD Reply

    Is it safer to do a TE echo first to determine clots in non anticoagulated patients off the street?

Leave a Reply Cancel Reply

Your email address will not be published. Required fields are marked *


*
*



Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2026 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603